SIRT3 regulates mitochondrial function and metabolic pathways through deacetylation modifications, and its overexpression can enhance mitochondrial biogenesis and inhibit the growth of ccRCC [18]. Here, SIRT3 is linked to nonpapillary renal cell carcinoma.